Campath-1H (anti-CD52) monoclonal antibody therapy in lymphoproliferative disorders (Q33340504)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Campath-1H (anti-CD52) monoclonal antibody therapy in lymphoproliferative disorders	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11778765

retrieved

25 July 2017

review article

1 reference

stated in

Europe PubMed Central

title

Campath-1H (anti-CD52) monoclonal antibody therapy in lymphoproliferative disorders (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11778765

retrieved

25 July 2017

main subject

antibody

1 reference

based on heuristic

inferred from title

lymphoproliferative disorders

1 reference

based on heuristic

inferred from title

monoclonal antibody

1 reference

based on heuristic

inferred from title

author name string

G A Pangalis

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11778765

retrieved

25 July 2017

M N Dimopoulou

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11778765

retrieved

25 July 2017

M K Angelopoulou

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11778765

retrieved

25 July 2017

C Tsekouras

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11778765

retrieved

25 July 2017

T P Vassilakopoulos

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11778765

retrieved

25 July 2017

G Vaiopoulos

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11778765

retrieved

25 July 2017

M P Siakantaris

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11778765

retrieved

25 July 2017

publication date

1 January 2001

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11778765

retrieved

25 July 2017

published in

Medical Oncology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11778765

retrieved

25 July 2017

volume

18

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11778765

retrieved

25 July 2017

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11778765

retrieved

25 July 2017

page(s)

99-107

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11778765

retrieved

25 July 2017

cites work

Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11a/CD18 (LFA-1) on NK cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo 'Purging' of residual disease in CLL with Campath-1H

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Humanized CD52 monoclonal antibody campath-1H as first-line treatment in chronic lymphocytic leukaemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Campath-1H in B-chronic lymphocytic leukemia: report on a patient treated thrice in a 3 year period

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The CAMPATH-1 antigen (CDw52)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunosuppressive toxicity of CAMPATH1H monoclonal antibody in the treatment of patients with recurrent low grade lymphoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Humanised monoclonal antibody therapy for rheumatoid arthritis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High level expression of the humanized monoclonal antibody Campath-1H in Chinese hamster ovary cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Old and new therapies in chronic lymphocytic leukemia: now is the time for a reassessment of therapeutic goals

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Campath-1G in vivo confers a low incidence of graft-versus-host disease associated with a high incidence of mixed chimaerism after bone marrow transplantation for severe aplastic anaemia using HLA-identical sibling donors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolonged Intermittent Chlorambucil Administration in B-Chronic Lymphocytic Leukemia: Experience from a Single Hematology Unit

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of T-cell prolymphocytic leukemia with human CD52 antibody

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Future strategies toward the cure of indolent B-cell malignancies. New biologic therapies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical analysis of CDw52 antigen expression in non-Hodgkin's lymphomas

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic lymphocytic leukemia: present status

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Removal of T cells from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complement

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T-cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapse

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of CAMPATH-1 antibodies in the treatment of lymphoid malignancies.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Indolent nonfollicular lymphomas: characteristics, treatment, and outcome.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recent results using CAMPATH-1 antibodies to control GVHD and graft rejection

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of monoclonal antibody therapy in patients with chronic lymphocytic leukemia.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autoimmune thrombocytopenic purpura complicating lymphoproliferative disorders

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibody therapy of diffuse cutaneous scleroderma with CAMPATH-1H.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subcutaneous CAMPATH-1H in fludarabine-resistant/relapsed chronic lymphocytic and B-prolymphocytic leukaemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of the CAMPATH-1 (CDw52) antigen: biochemical analysis and cDNA cloning reveal an unusually small peptide backbone

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CAMPATH-1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpura

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adverse reactions to Campath-1H monoclonal antibody

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Removal of T cells from bone marrow for transplantation. Comparison of rat monoclonal anti-lymphocyte antibodies of different isotypes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

B-chronic lymphocytic leukemia, small lymphocytic lymphoma, and lymphoplasmacytic lymphoma, including Waldenström's macroglobulinemia: a clinical, morphologic, and biologic spectrum of similar disorders.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous Transplantation with CD52 Monoclonal Antibody-Purged Marrow for Acute Lymphoblastic Leukemia: Long-Term Follow-Up

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Levels of expression of CD52 in normal and leukemic B and T cells: correlation with in vivo therapeutic responses to Campath-1H

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Importance of antigen specificity for complement-mediated lysis by monoclonal antibodies.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy for non-Hodgkin's lymphoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ex vivo depletion of T cells from bone marrow grafts with CAMPATH-1 in acute leukemia: graft-versus-host disease and graft-versus-leukemia effect

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clonal CD8+ and CD52- T cells are induced in responding B cell lymphoma patients treated with Campath-1H (anti-CD52)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal-Antibody Therapy in Systemic Vasculitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Remission Induction in Patients with Lymphoid Malignancies Using Unconjugated CAMPATH-1 Monoclonal Antibodies.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advances in immunotherapy of hematologic malignancies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reshaping human antibodies for therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11778765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1385/MO:18:2:99

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11778765

retrieved

25 July 2017

Dimensions Publication ID

1011124976

0 references

PubMed publication ID

11778765

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11778765

retrieved

25 July 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33340504&oldid=2195261101"